Scientific Publications | Max Delbrück Center

179 Results:

Active Filter:

Blankenstein, Thomas Prof. Dr.

March 14, 2023 / J Immunother Cancer

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

March 01, 2023 / Nat Immunol

IFNγ binding to extracellular matrix prevents fatal systemic toxicity

J. Kemna
E. Gout
L. Daniau
J. Lao
K. Weißert
S. Ammann
R. Kühn
M. Richter
C. Molenda
A. Sporbert
D. Zocholl
R. Klopfleisch
H. Lortat-Jacob
P. Aichele
T. Kammertoens
T. Blankenstein

February 16, 2023 / Front Immunol

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

L. Immisch
G. Papafotiou
N. Gallarín Delgado
V. Scheuplein
A. Paschen
T. Blankenstein
G. Willimsky

February 01, 2023 / J Immunother Cancer

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy

N. Plewa
L. Poncette
T. Blankenstein

November 01, 2022 / Cancer Immunol Res

Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma

C. Welters
M.F. Lammoglia Cobo
C.A. Stein
M.T. Hsu
A. Ben Hamza
L. Penter
X. Chen
C. Buccitelli
O. Popp
P. Mertins
K. Dietze
L. Bullinger
A. Moosmann
E. Blanc
D. Beule
A. Gerbitz
J. Strobel
H. Hackstein
H.P. Rahn
K. Dornmair
T. Blankenstein
L. Hansmann

October 27, 2022 / J Immunother Cancer

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

August 01, 2022 / Cytotherapy

Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy

M.F. Lammoglia Cobo
C. Welters
L. Rosenberger
M. Leisegang
K. Dietze
C. Pircher
L. Penter
R. Gary
L. Bullinger
A. Takvorian
A. Moosmann
K. Dornmair
T. Blankenstein
T. Kammertöns
A. Gerbitz
L. Hansmann

June 08, 2022 / Sci Adv

IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis

L. Garnier
R. Pick
J. Montorfani
M. Sun
D. Brighouse
N. Liaudet
T. Kammertoens
T. Blankenstein
N. Page
J. Bernier-Latamani
N.L. Tran
T.V. Petrova
D. Merkler
C. Scheiermann
S. Hugues

April 06, 2022 / Cancers

Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires

C. Grunert
G. Willimsky
C.A. Peuker
S. Rhein
L. Hansmann
T. Blankenstein
E. Blanc
D. Beule
U. Keller
A. Pezzutto
A. Busse

February 01, 2022 / Curr Opin Immunol

The role of CD4 T cells in rejection of solid tumors

L. Poncette
J. Bluhm
T. Blankenstein